
N-[2-(diethylamino)ethyl]-2-iodobenzamide
CAS No. 170794-62-4
N-[2-(diethylamino)ethyl]-2-iodobenzamide( —— )
Catalog No. M28941 CAS No. 170794-62-4
N-[2-(diethylamino)ethyl]-2-iodobenzamide is a radiopharmaceutical for the scintigraphic detection of melanoma and metastases.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 50 | Get Quote |
![]() ![]() |
10MG | 67 | Get Quote |
![]() ![]() |
25MG | 102 | Get Quote |
![]() ![]() |
50MG | 146 | Get Quote |
![]() ![]() |
100MG | 213 | Get Quote |
![]() ![]() |
500MG | 533 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameN-[2-(diethylamino)ethyl]-2-iodobenzamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-[2-(diethylamino)ethyl]-2-iodobenzamide is a radiopharmaceutical for the scintigraphic detection of melanoma and metastases.
-
DescriptionN-[2-(diethylamino)ethyl]-2-iodobenzamide is a radiopharmaceutical for the scintigraphic detection of melanoma and metastases.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorβ-adrenergic receptor|α-adrenergic receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number170794-62-4
-
Formula Weight346.21
-
Molecular FormulaC13H19IN2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCN(CC)CCNC(=O)C1=CC=CC=C1I
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jin WL, et al. Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta. Diabetologia. 2011 Jul;54(7):1921-9.
molnova catalog



related products
-
Lignin
Lignin is the main component of plant cell walls and is a renewable aromatic polymer. Lignin has strongly antioxidant activity.Lignin (Lignine) is a natural complex biopolymer with biodegradable and biocompatible.
-
Poloxamer 407
Poloxamer 407 is a nonionic surfactant.
-
BMS-927711
BMS-927711 is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki value of 0.027 nM.